Addus director awarded 1,449 restricted shares

RUSH JEAN reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

RUSH JEAN reported acquisition or exercise transactions in this Form 4 filing.

Addus HomeCare Corp director Jean Rush received an equity grant of company stock. The Form 4 reports an award of 1,449 shares of Common Stock at no cash cost, increasing her directly held stake to 10,670 shares after the transaction.

According to the footnote, these are restricted shares granted to non-employee directors that will vest in full on June 10, 2027, meaning they are subject to service-based conditions until that date.

Insider Trade Summary

Grant/Award: 1,449 shares

Grant/Award 1 txn

Insider RUSH JEAN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,449	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,670 shares (Direct)

Footnotes (1)

1. F1. Restricted shares granted to non-employee directors that will vest in full on June 10, 2027.

Key Figures

Restricted stock grant: 1,449 shares Grant price: $0.0000 per share Shares after transaction: 10,670 shares +1 more

4 metrics

Restricted stock grant 1,449 shares Common Stock award to non-employee director

Grant price $0.0000 per share Equity compensation, not a cash purchase

Shares after transaction 10,670 shares Director’s direct holdings following grant

Vesting date June 10, 2027 Restricted shares vest in full on this date

Key Terms

Restricted shares, non-employee directors, vest in full, Grant, award, or other acquisition

4 terms

Restricted shares financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

non-employee directors financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

vest in full financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Addus HomeCare (ADUS) director Jean Rush report?

Director Jean Rush reported receiving an award of 1,449 shares of Addus HomeCare Common Stock. The shares were granted at no cash cost as equity compensation and increased her directly held position to 10,670 shares following the transaction.

When do Jean Rush’s newly granted Addus HomeCare (ADUS) restricted shares vest?

The restricted shares granted to Jean Rush will vest in full on June 10, 2027. Until that vesting date, the award remains subject to its restrictions, which typically require continued board service as a non-employee director to receive the shares outright.

How many Addus HomeCare (ADUS) shares does Jean Rush hold after this Form 4 grant?

After the reported grant, Jean Rush directly holds 10,670 shares of Addus HomeCare Common Stock. This total includes the 1,449 newly awarded restricted shares, which are part of her overall equity-based compensation as a non-employee director of the company.

Did Jean Rush buy or sell Addus HomeCare (ADUS) shares in this Form 4 filing?

The Form 4 shows an acquisition through a grant, not an open-market buy or sale. Jean Rush received 1,449 restricted shares as a compensation award, with a reported price of $0.0000 per share rather than a cash purchase or sale transaction.

What type of equity award did Addus HomeCare (ADUS) grant to director Jean Rush?

Jean Rush received restricted shares of Addus HomeCare Common Stock as a non-employee director. The award covers 1,449 shares that will vest in full on June 10, 2027, aligning her compensation with long-term shareholder interests through stock ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RUSH JEAN

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TEXAS 75034

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		1,449(1)	A	$0	10,670	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 10, 2027.

	/s/ Brian Poff, Attorney-In-Fact for Jean Rush	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)